HB-EGF protects intestines from a variety of injuries, pair of studies suggests

August 20, 2013, Nationwide Children's Hospital

It's not often that one treatment offers therapeutic potential for multiple conditions. However, after more than two decades of research, Gail Besner, MD, principal investigator for the Center for Perinatal Research and pediatric surgeon for the Department of Pediatric Surgery at Nationwide Children's Hospital, and her team have found that this may just be the case with HB-EGF, or heparin-binding EGF-like growth factor.

Having discovered the growth factor in 1990, Dr. Besner most recently conducted two studies in mice published in June in the Journal of Pediatric Surgery that reveal the potential of HB-EGF to protect the from diverse types of injury. The first offers evidence that treatment with the growth factor may help the intestines protect themselves from damage after exposure to .

"Many patients are treated with radiation therapy for pelvic and abdominal cancers each year, and over half suffer from injury to the intestines as a result, which may limit their ability to receive additional therapy," Dr. Besner says. "In the future, treatment with HB-EGF may protect the intestines from this injury, enabling patients to receive more therapy, or at least not suffer as much damage from the radiation."

HB-EGF is a protein that stimulates cells to grow and to move. Cell proliferation and migration are critical to wound healing, including the healing of intestinal . In addition, HB-EGF decreases the production of multiple substances that are formed upon intestinal injury and that would normally act to worsen the injury. This allows the protein to protect the intestine from further harm.

To boost the potential protective potency of HB-EGF, Dr. Besner and her lab directed a second study involving stem cell administration, which is increasingly used to protect organs from injury. "We demonstrated that administration of HB-EGF protects the intestines from injury, and administration of protects the intestines from injury—but treatment with both therapies simultaneously acts synergistically to further protect the intestines from injury."

Together, the results of the two studies offer Dr. Besner encouragement for a healthier future for her tiny patients. Newborns, especially those born prematurely, are at particular risk of an injury to the intestines known as necrotizing enterocolitis, or NEC. Dr. Besner's research suggests HB-EGF may hold significant clinical potential for these babies.

"The mortality of NEC is too high, despite widespread research on it—if I operate on one of these babies, I have to tell the parents that their baby only has a 50 percent chance of living," Dr. Besner says. "Because of this, I am very motivated to find a cure. Mounting work from our laboratory shows that HB-EGF can protect the intestines from NEC. It is our hope that, in the future, we can administer HB-EGF to newborns most at risk of developing NEC in order to prevent them from developing this devastating disease."

Having studied the potential for therapeutic applications of HB-EGF for more than two decades, Dr. Besner is optimistic about the protein's potential. "We have some very exciting new lines of HB-EGF research going on in our laboratory at present, and we feel that the future for HB-EGF use in the treatment of human clinical disease remains bright."

Explore further: Epidermal growth factor aids stem cell regeneration after radiation damage

More information: Matthews MA, Watkins D, Darbyshire A, Caron WE, Besner GE. Heparin-Binding EGF-like Growth Factor (HB-EGF) Protects the Intestines from Radiation Therapy-Induced Intestinal Injury. Journal of Pediatric Surgery. 2013 Jun, 48(6):1316-1322.

Watkins DJ, Yang J, Matthews MA, Besner GE. Synergistic Effects of HG-EGF and Mesenchymal Stem Cells in a Murine Model of Intestinal Ischemia/Reperfusion Injury. Journal of Pediatric Surgery. 2013 Jun, 48(6):1323-1329.

Related Stories

Epidermal growth factor aids stem cell regeneration after radiation damage

February 3, 2013
Epidermal growth factor has been found to speed the recovery of blood-making stem cells after exposure to radiation, according to Duke Medicine researchers. The finding could open new options for treating cancer patients ...

Cancer biology: Keeping bad company

January 16, 2013
The p53 tumor suppressor protein manages DNA repair mechanisms in response to genetic damage and kills off precancerous cells before they multiply. The loss of p53 due to mutation greatly increases risk of tumorigenesis. ...

Modified formula aims to prevent death in premature infants

May 10, 2013
Necrotizing Entercolitis, an infection and inflammation that causes destruction of the intestine,affects about 10,000 babies a year in the country, and mortality rates are roughly 40 percent.

Rogue receptor opens door for rare kidney disease

September 25, 2011
Effects of a particularly devastating human kidney disease may be blunted by making a certain cellular protein receptor much less receptive, according to new research by scientists from North Carolina State University and ...

Recommended for you

Drug may help surgical patients stop opioids sooner

December 13, 2017
(HealthDay)—Opioid painkillers after surgery can be the first step toward addiction for some patients. But a common drug might cut the amount of narcotics that patients need, a new study finds.

Children best placed to explain facts of surgery to patients, say experts

December 13, 2017
Getting children to design patient information leaflets may improve patient understanding before they have surgery, finds an article in the Christmas issue of The BMJ.

Burn victim saved by skin grafts from identical twin (Update)

November 23, 2017
A man doomed to die after suffering burns across 95 percent of his body was saved by skin transplants from his identical twin in a world-first operation, French doctors said Thursday.

Is a common shoulder surgery useless?

November 21, 2017
(HealthDay)—New research casts doubt on the true effectiveness of a common type of surgery used to ease shoulder pain.

Study shows electric bandages can fight biofilm infection, antimicrobial resistance

November 6, 2017
Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic ...

Obesity increases incidence, severity, costs of knee dislocations

November 3, 2017
A new study of more than 19,000 knee dislocation cases in the U.S. between 2000 and 2012 provides a painful indication of how the nation's obesity epidemic is changing the risk, severity and cost of a traumatic injury.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.